Arcturus Therapeutics Holdings (ARCT) Change in Receivables (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Change in Receivables data on file, last reported at -$4.2 million in Q1 2026.

• Quarterly Change in Receivables fell 139.83% year-over-year to -$4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.2 million (down 5.96% YoY) and the FY2025 annual result came in at $1.6 million, up 105.66% from the prior year.
• Change in Receivables retreated to -$4.2 million in Q1 2026, from -$2.4 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $89.7 million in Q1 2023 to a low of -$89.7 million in Q2 2023.
• A 5-year average of -$119058.8 and a median of -$1.4 million in 2022 frame the typical range for Change in Receivables.
• The widest YoY moves for Change in Receivables: up 27591.05% in 2023, down 6110.8% in 2023.
• Tracing ARCT's Change in Receivables over 5 years: stood at $720000.0 in 2022, then sank by 955.0% to -$6.2 million in 2023, then slumped by 326.01% to -$26.2 million in 2024, then jumped by 90.9% to -$2.4 million in 2025, then sank by 76.83% to -$4.2 million in 2026.
• The last three Change in Receivables figures came in at -$4.2 million (Q1 2026), -$2.4 million (Q4 2025), and -$9.3 million (Q3 2025), per Business Quant data.